Ghost Tree Capital Has Trimmed Vanda Pharmaceuticals (VNDA) Holding By $975,000; Digiliti Money Group (DGLT) Shorts Lowered By 28.18%

August 8, 2017 - By Ellis Scott

Ghost Tree Capital Llc decreased Vanda Pharmaceuticals Inc (VNDA) stake by 58.56% reported in 2016Q4 SEC filing. Ghost Tree Capital Llc sold 65,000 shares as Vanda Pharmaceuticals Inc (VNDA)’s stock declined 5.00%. The Ghost Tree Capital Llc holds 46,000 shares with $734,000 value, down from 111,000 last quarter. Vanda Pharmaceuticals Inc now has $725.14 million valuation. The stock rose 0.72% or $0.12 reaching $16.17. About 97,248 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 51.60% since August 8, 2016 and is uptrending. It has outperformed by 34.90% the S&P500.

Digiliti Money Group Incorporated (NASDAQ:DGLT) had a decrease of 28.18% in short interest. DGLT’s SI was 7,900 shares in August as released by FINRA. Its down 28.18% from 11,000 shares previously. With 35,400 avg volume, 0 days are for Digiliti Money Group Incorporated (NASDAQ:DGLT)’s short sellers to cover DGLT’s short positions. The SI to Digiliti Money Group Incorporated’s float is 0.61%. About 1.12 million shares traded or 1775.07% up from the average. Digiliti Money Group Inc (NASDAQ:DGLT) has 0.00% since August 8, 2016 and is . It has underperformed by 16.70% the S&P500.

Among 7 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 14 analyst reports since September 2, 2015 according to SRatingsIntel. The rating was maintained by JMP Securities with “Market Outperform” on Friday, August 26. The stock has “Buy” rating by Jefferies on Monday, June 26. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, September 2. The rating was reinitiated by Jefferies on Thursday, October 6 with “Buy”. H.C. Wainwright maintained it with “Buy” rating and $1800 target in Thursday, August 3 report. Piper Jaffray initiated it with “Buy” rating and $2300 target in Tuesday, June 27 report. Piper Jaffray maintained it with “Buy” rating and $2300 target in Thursday, August 3 report. As per Thursday, August 3, the company rating was maintained by Oppenheimer. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has “Market Outperform” rating given on Wednesday, March 9 by JMP Securities. The stock has “Buy” rating by Aegis Capital on Wednesday, November 9.

Ghost Tree Capital Llc increased Neuroderm Ltd stake by 199,000 shares to 330,000 valued at $7.33 million in 2016Q4. It also upped Dbv Technologies S A stake by 75,000 shares and now owns 325,000 shares. Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) was raised too.

Investors sentiment decreased to 1.29 in 2016 Q4. Its down 1.10, from 2.39 in 2016Q3. It is negative, as 12 investors sold VNDA shares while 46 reduced holdings. 20 funds opened positions while 55 raised stakes. 39.66 million shares or 1.45% less from 40.25 million shares in 2016Q3 were reported. Prelude Mgmt Ltd Liability Corp stated it has 0.01% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Aqr Capital Mgmt Lc reported 13,973 shares. First Mercantile Trust holds 6,490 shares or 0.02% of its portfolio. Northern Tru Corp holds 484,552 shares or 0% of its portfolio. Moreover, Alliancebernstein LP has 0% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Armistice Capital Llc invested 2.19% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Moreover, State Street has 0% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 1.75 million shares. Piermont Capital Mgmt accumulated 37,800 shares. Manufacturers Life The has 25,270 shares for 0% of their portfolio. Tudor Investment Corp Et Al accumulated 50,547 shares. Schwab Charles Inv Mngmt Inc reported 0.01% stake. Bogle Investment Mngmt Limited Partnership De reported 0.5% stake. Pdt Ptnrs Ltd has 108,860 shares. Qs Limited Liability Com accumulated 0.05% or 351,241 shares. Federated Pa reported 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).